Assignee
PREXTON THERAPEUTICS SA
CH·3 granted patents·2 pending applications·5 citations·filing 2015–2019
Top patents by PatentIndex Score
5 records- 0176US10017521B2Chromone oxime derivative and its use as allosteric modulator of metabotropic glutamate receptorsPREXTON THERAPEUTICS SA·Filed 2015·Granted Jul 10, 2018·3 cites·15 claims
- 0274US10442818B2Chromone oxime derivative and its use as allosteric modulator of metabotropic glutamate receptorsPREXTON THERAPEUTICS SA·Filed 2018·Granted Oct 15, 2019·1 cites·5 claims
- 0366US10532057B2Brain-penetrant chromone oxime derivative for the therapy of levodopa-induced dyskinesiaPREXTON THERAPEUTICS SA·Filed 2016·Granted Jan 14, 2020·1 cites·20 claims
- 0453US2020171042A1Brain-penetrant chromone oxime derivative for the therapy of levodopa-induced dyskinesiaPREXTON THERAPEUTICS SA·Filed 2019·Application pending·0 cites
- 0552US2020024285A1Novel chromone oxime derivative and its use as allosteric modulator of metabotropic glutamate receptorsPREXTON THERAPEUTICS SA·Filed 2019·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →